The Medical Minute: Robotic surgery for treatment of prostate cancer

Sep 25, 2009 By Jay D. Raman

(PhysOrg.com) -- Prostate cancer is the most commonly diagnosed cancer in the United States (excluding skin cancers) and is second only to lung cancer as a contributor to cancer deaths in American men.

In 2009, it is estimated that 192,280 new cases will be diagnosed and more than 27,000 men will die of prostate cancer. The lifetime probability of developing prostate cancer is one in six for American men. Current treatment alternatives for clinically localized prostate cancer include removal of the prostate gland (surgery), radiation to the cancerous prostate (external beam or radioactive seed implants), active surveillance, or other treatments (hormonal or cryotherapy).

Radical prostatectomy via an open approach has historically been the gold standard therapy for the surgical treatment of . While oncologic and functional outcomes following open radical prostatectomy are excellent, prolonged recovery is a legitimate concern for physicians and patients. With such considerations, an impetus within the surgical community has been to reduce the complications of procedures without compromising on established standards of care. To that end, laparoscopic surgery, which is performed via several tiny holes rather than one long incision, has been shown to reduce perioperative complications while improving recovery. Robotic surgery represents the next potential iteration for advances in minimally invasive surgery.

The first robotic-assisted surgery performed in 1995 utilized a robotic platform to eliminate the need for an assistant to hold the camera during laparoscopic procedures. The more contemporary da Vinci system represents the next evolutionary step, offering an instrument that can control a camera with one hand while simultaneously manipulating tiny laparoscopic surgical tools in its other hands. With a human surgeon at the controls, da Vinci filters out tremor, enhances precision, offers three-dimensional imaging and may eliminate some of the fatigue associated with conventional laparoscopy.

Robotic surgery appears particularly advantageous from the standpoint of added precision for some procedures. It has experienced great popularity for urologic surgery; particularly cancers of the prostate located deep in the pelvis. Current utilization, however, is quite widespread including applications for general surgery (esophagus, stomach, and biliary reconstruction), cardiac (coronary artery bypass grafting and valve replacement), and gynecology (hysterectomy, oopherectomy, and tubal reconstruction). It is likely that the array of surgical procedures performed with robotic technology only will increase over time.

Starting fall 2009, Penn State Milton S. Hershey Medical Center will be home to the newest robotic system, the da Vinci SI system, and surgeons will be offering this newest surgical advancement to patients in central Pennsylvania.

Provided by Pennsylvania State University (news : web)

Explore further: The fine line between breast cancer and normal tissues

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

The fine line between breast cancer and normal tissues

13 hours ago

Up to 40 percent of patients undergoing breast cancer surgery require additional operations because surgeons may fail to remove all the cancerous tissue in the initial operation. However, researchers at Brigham ...

Pancreatic cancer risk not higher with diabetes Rx DPP-4i

14 hours ago

(HealthDay)—There is no increased short-term pancreatic cancer risk with dipeptidyl-peptidase-4 inhibitors (DPP-4i) compared to sulfonylureas (SU) and thiazolidinediones (TZD) for glycemic control, according ...

Good bowel cleansing is key for high-quality colonoscopy

17 hours ago

The success of a colonoscopy is closely linked to good bowel preparation, with poor bowel prep often resulting in missed precancerous lesions, according to new consensus guidelines released by the U.S. Multi-Society Task ...

New rules for anticancer vaccines

18 hours ago

Scientists have found a way to find the proverbial needle in the cancer antigen haystack, according to a report published in The Journal of Experimental Medicine.

User comments : 0